[{"id":"breakthrough-designation","kind":"term","name":"Breakthrough Therapy / Priority Review / Priority Voucher","route":"/terms/breakthrough-designation/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/terms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Breakthrough_therapy\""}]},{"id":"breakthrough-designation","kind":"term","name":"Breakthrough Therapy / Priority Review / Priority Voucher","route":"/terms/breakthrough-designation/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/terms.ts","type":"changed","fields":[{"field":"tldr","before":"\"FDA fast lanes for drugs that look substantially better than existing options.\"","after":"\"Breakthrough Therapy, Priority Review and the Priority Voucher are FDA fast lanes for drugs that look substantially better than existing options.\""}]}]